The purpose of this study was to characterize the sEVs from APS patients in terms of their concentration, size and selected surface proteins, as well as to identify the potential differences from healthy blood donors (HBD) and aPL-negative patients with idiopathic thrombosis (aPL-neg IT). The gene discussed is FASLG; the disease is deep vein thrombosis.